Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

W Berger

Showing results (691-700 of 730) with videos related to

Pageof 73
Sort By:
Human Genetics|November 1, 1992
Generation and characterization of radiation reduced cell hybrids and isolation of probes from the proximal short arm of the human X chromosomeW Berger, A Meindl, B de Leeuw, et al.
Mbio|November 6, 2014
Evolution of invasion in a diverse set of Fusobacterium speciesAbigail Manson McGuire, Kyla Cochrane, Allison D Griggs, et al.
Nature Genetics|November 4, 2000
The complete form of X-linked congenital stationary night blindness is caused by mutations in a gene encoding a leucine-rich repeat proteinC M Pusch, C Zeitz, O Brandau, et al.
United European Gastroenterology Journal|March 8, 2018
Genetic Biopsy for Prediction of Surveillance Intervals after Endoscopic Resection of Colonic Polyps: Results of the GENESIS StudyAndreas W Berger, Katja Raedler, Cord Langner, et al.
Frontiers in Systems Biology|August 14, 2025
Surface-displayed silicatein-α enzyme in bioengineered <i>E. coli</i> enables biocementation and silica mineralizationToriana N Vigil, Nikolas K Schwendeman, Melanie L M Grogger, et al.
Gastroenterology|June 26, 2016
Detection of Hot-Spot Mutations in Circulating Cell-Free DNA From Patients With Intraductal Papillary Mucinous Neoplasms of the PancreasAndreas W Berger, Daniel Schwerdel, Ivan G Costa, et al.
Neuroscience and Biobehavioral Reviews|January 30, 2017
Immobility reactions under threat: A contribution to human defensive cascade and PTSDE Volchan, V Rocha-Rego, A F Bastos, et al.
BMC Cancer|January 17, 2016
DocOx (AIO-PK0106): a phase II trial of docetaxel and oxaliplatin as a second line systemic therapy in patients with advanced pancreatic ductal adenocarcinomaThomas J Ettrich, Lukas Perkhofer, Goetz von Wichert, et al.
Environmental Science. Advances|February 7, 2024
A comprehensive trial on PFAS remediation: hemp phytoextraction and PFAS degradation in harvested plantsSara L Nason, Sara Thomas, Chelli Stanley, et al.
International Journal of Cancer|September 15, 2020
Nintedanib plus mFOLFOX6 as second-line treatment of metastatic, chemorefractory colorectal cancer: The randomised, placebo-controlled, phase II TRICC-C study (AIO-KRK-0111)Thomas J Ettrich, Lukas Perkhofer, Thomas Decker, et al.
Pageof 73

Showing results (691-700 of 730) with videos related to

Sort By:
Pageof 73
Human Genetics|November 1, 1992
Generation and characterization of radiation reduced cell hybrids and isolation of probes from the proximal short arm of the human X chromosomeW Berger, A Meindl, B de Leeuw, et al.
Mbio|November 6, 2014
Evolution of invasion in a diverse set of Fusobacterium speciesAbigail Manson McGuire, Kyla Cochrane, Allison D Griggs, et al.
Nature Genetics|November 4, 2000
The complete form of X-linked congenital stationary night blindness is caused by mutations in a gene encoding a leucine-rich repeat proteinC M Pusch, C Zeitz, O Brandau, et al.
United European Gastroenterology Journal|March 8, 2018
Genetic Biopsy for Prediction of Surveillance Intervals after Endoscopic Resection of Colonic Polyps: Results of the GENESIS StudyAndreas W Berger, Katja Raedler, Cord Langner, et al.
Frontiers in Systems Biology|August 14, 2025
Surface-displayed silicatein-α enzyme in bioengineered <i>E. coli</i> enables biocementation and silica mineralizationToriana N Vigil, Nikolas K Schwendeman, Melanie L M Grogger, et al.
Gastroenterology|June 26, 2016
Detection of Hot-Spot Mutations in Circulating Cell-Free DNA From Patients With Intraductal Papillary Mucinous Neoplasms of the PancreasAndreas W Berger, Daniel Schwerdel, Ivan G Costa, et al.
Neuroscience and Biobehavioral Reviews|January 30, 2017
Immobility reactions under threat: A contribution to human defensive cascade and PTSDE Volchan, V Rocha-Rego, A F Bastos, et al.
BMC Cancer|January 17, 2016
DocOx (AIO-PK0106): a phase II trial of docetaxel and oxaliplatin as a second line systemic therapy in patients with advanced pancreatic ductal adenocarcinomaThomas J Ettrich, Lukas Perkhofer, Goetz von Wichert, et al.
Environmental Science. Advances|February 7, 2024
A comprehensive trial on PFAS remediation: hemp phytoextraction and PFAS degradation in harvested plantsSara L Nason, Sara Thomas, Chelli Stanley, et al.
International Journal of Cancer|September 15, 2020
Nintedanib plus mFOLFOX6 as second-line treatment of metastatic, chemorefractory colorectal cancer: The randomised, placebo-controlled, phase II TRICC-C study (AIO-KRK-0111)Thomas J Ettrich, Lukas Perkhofer, Thomas Decker, et al.
Pageof 73